Skip to main content
. Author manuscript; available in PMC: 2010 Sep 8.
Published in final edited form as: Biol Psychiatry. 2009 Jul 9;66(5):522–526. doi: 10.1016/j.biopsych.2009.04.029

FIGURE 1.

FIGURE 1

Individual patient scores on the Montgomery-Asberg Rating Scale—Suicide item at baseline (Day 1; 150 minutes prior to infusion), 24-hours following a single subanesthetic infusion of ketamine (Day 2), and 4-hours following the final repeated infusion (Day 12 of study; Panel 2 only).